Mark Thomas

Dr

  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth

    Australia

  • 350 Citations
  • 9 h-Index
20002018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mark Thomas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 350 Citations
  • 9 h-Index
  • 18 Article
  • 3 Review article
  • 2 Chapter
  • 1 Letter

Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study

Hughes, J. T., Maple-Brown, L. J., Thomas, M., Lawton, P. D., Sinha, A., Cass, A., Barzi, F., Jones, G. R. D., Jerums, G., MacIsaac, R. J., O'Dea, K. & Hoy, W. E., 1 Jan 2018, In : Nephrology. 23, 1, p. 37-45 9 p.

Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Bilirubin concentration is positively associated with haemoglobin concentration and inversely associated with albumin to creatinine ratio among Indigenous Australians: eGFR Study

    Hughes, J. T., Barzi, F., Hoy, W. E., Jones, G. R. D., Rathnayake, G., Majoni, S. W., Thomas, M. A. B., Sinha, A., Cass, A., MacIsaac, R. J., O'Dea, K. & Maple-Brown, L. J., Dec 2017, In : Clinical Biochemistry. 50, 18, p. 1040-1047 8 p.

    Research output: Contribution to journalArticle

    3 Citations (Scopus)

    Mesorhizobium peritonitis: The first reported case

    Krishnan, A., Raby, E., Puttagunta, H., Leung, M. & Thomas, M., 1 Jan 2017, In : Nephrology. 22, 1, p. 96 1 p.

    Research output: Contribution to journalLetter

    Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

    Hughes, D. A., Nicholls, K., Shankar, S. P., Sunder-Plassmann, G., Koeller, D., Nedd, K., Vockley, G., Hamazaki, T., Lachmann, R., Ohashi, T., Olivotto, I., Sakai, N., Deegan, P., Dimmock, D., Eyskens, F., Germain, D. P., Goker-Alpan, O., Hachulla, E., Jovanovic, A., Lourenco, C. M. & 18 othersNarita, I., Thomas, M., Wilcox, W. R., Bichet, D. G., Schiffmann, R., Ludington, E., Viereck, C., Kirk, J., Yu, J., Johnson, F., Boudes, P., Benjamin, E. R., Lockhart, D. J., Barlow, C., Skuban, N., Castelli, J. P., Barth, J. & Feldt-Rasmussen, U., 1 Apr 2017, In : Journal of Medical Genetics. 54, 4, p. 288-296 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 90 Citations (Scopus)

    Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

    Prosser, H. C., Gregory, C., Hering, D., Hillis, G. S., Perry, G., Rosman, J., Schultz, C., Thomas, M., Watts, G. F. & Schlaich, M. P., 1 Apr 2017, In : Current Hypertension Reports. 19, 4, 30.

    Research output: Contribution to journalReview article

  • 3 Citations (Scopus)